Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias P Ebert

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Signal Transduction and Targeted Therapy|May 8, 2024
Unveiling the culprit: the fusobacterium lineage that populates colorectal cancerJohannes Betge, Matthias P Ebert
Journal of Gastrointestinal and Liver Diseases : JGLD|March 20, 2022
Endoscopy capsule in the scrotumJohannes Betge, Maximilian Wekerle, Matthias P Ebert
European Journal of Gastroenterology & Hepatology|October 16, 2003
High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not?Manfred Stolte, Michael Vieth, Matthias P Ebert
Expert Review of Anticancer Therapy|October 20, 2007
Need for a paradigm shift in cancer prevention and clinical oncologyMatthias P Ebert, Roland Schmid, Christoph Röcken
Gastrointestinal Tumors|December 18, 2015
Gastric Cancer: New Drugs - New StrategiesNadin Schulte, Matthias P Ebert, Nicola Härtel
Therapeutic Advances in Medical Oncology|March 3, 2022
Precision medicine for metastatic colorectal cancer in clinical practiceJulian E Riedesser, Matthias P Ebert, Johannes Betge
Seminars in Cancer Biology|May 3, 2018
Checkpoints and beyond - Immunotherapy in colorectal cancerTobias Gutting, Elke Burgermeister, Nicolai Härtel, et al.
Zeitschrift Fur Gastroenterologie|June 17, 2020
[Gastrointestinal tumors in older patients]Nadine Schulte, Matthias P Ebert, Christoph Reissfelder, et al.
Trends in Molecular Medicine|June 24, 2025
Gastric cancer: from biomarkers to functional precision medicinePhilipp Albrecht, Ekin Karabati, Matthias P Ebert, et al.
Anticancer Research|May 30, 2008
Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistanceLilach Tencer, Elke Burgermeister, Matthias P Ebert, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Signal Transduction and Targeted Therapy|May 8, 2024
Unveiling the culprit: the fusobacterium lineage that populates colorectal cancerJohannes Betge, Matthias P Ebert
Journal of Gastrointestinal and Liver Diseases : JGLD|March 20, 2022
Endoscopy capsule in the scrotumJohannes Betge, Maximilian Wekerle, Matthias P Ebert
European Journal of Gastroenterology & Hepatology|October 16, 2003
High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not?Manfred Stolte, Michael Vieth, Matthias P Ebert
Expert Review of Anticancer Therapy|October 20, 2007
Need for a paradigm shift in cancer prevention and clinical oncologyMatthias P Ebert, Roland Schmid, Christoph Röcken
Gastrointestinal Tumors|December 18, 2015
Gastric Cancer: New Drugs - New StrategiesNadin Schulte, Matthias P Ebert, Nicola Härtel
Therapeutic Advances in Medical Oncology|March 3, 2022
Precision medicine for metastatic colorectal cancer in clinical practiceJulian E Riedesser, Matthias P Ebert, Johannes Betge
Seminars in Cancer Biology|May 3, 2018
Checkpoints and beyond - Immunotherapy in colorectal cancerTobias Gutting, Elke Burgermeister, Nicolai Härtel, et al.
Zeitschrift Fur Gastroenterologie|June 17, 2020
[Gastrointestinal tumors in older patients]Nadine Schulte, Matthias P Ebert, Christoph Reissfelder, et al.
Trends in Molecular Medicine|June 24, 2025
Gastric cancer: from biomarkers to functional precision medicinePhilipp Albrecht, Ekin Karabati, Matthias P Ebert, et al.
Anticancer Research|May 30, 2008
Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistanceLilach Tencer, Elke Burgermeister, Matthias P Ebert, et al.
Pageof 14